TMCnet News
Research and Markets: Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth DriversDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/3t5jtr/glucose) has announced the addition of the "Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers" report to their offering. Glucose Monitoring Devices Market: Asia-Pacific to Boost Moderate Growth by 2019. The global glucose monitoring devices market value will experience a moderate increase from $9.9 billion in 2012 to $13.7 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 5% According to the company's latest report*, emerging countries, such as China and India, show the most potential for market growth, as they have the largest diabetic populations consisting of 92 million and 63 million people, respectively. In fact, the Asia-Pacific market for glucose monitoring is expected to double from $1.5 billion in 2012 to $3 billion by 2019, at a CAGR of 10%. Still, the US and Europe will continue to lead this setting by 2019, with shares of 34% and 40%, respectively. Srikanth Venkataraman, report analyst, says: Rapid urbanization and changes in lifestyle habits have made people in developing countries especially vulnerable to disorders such as diabetes. Hwever, poor healthcare infrastructure, urban-rural disparity and a lack of skilled healthcare professionals have previously limited the adoption and use of devices for the prevention and treatment of diabetes in these markets. The authors now expect the increasing awareness of the importance of glucose monitoring, along with technical innovations minimizing the blood required for glucose testing, to drive the adoption of such devices in the Asia-Pacific region during the forecast period. Venkataraman says: One of the key technological developments in the diabetes care industry is Continuous Glucose Monitoring (CGM), which helps patients to measure glucose levels regularly, unlike traditional devices. CGM devices are programmed to alert users to low or high glucose levels, allowing for timely medication and reducing any risk of associated complications due to undesired changes in glycemic levels. With diabetes becoming an increasingly major burden globally, the authors believe that early detection through regular monitoring can improve the control and treatment of the disease. This report provides information on market size for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets. Countries covered include the US, Canada, Germany, France, Italy, Spain, the UK, Japan, China, India, Australia and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Global Glucose Monitoring Device Market: Device Overview Global Glucose Monitoring Device Market: Market Characterization Global Glucose Monitoring Device Market: Segment Analysis and Forecasts Global Glucose Monitoring Device Market: Country Analysis and Forecasts Global Glucose Monitoring Device Market: Reimbursement System Global Glucose Monitoring Device Market: Competitive Landscape Global Glucose Monitoring Device Market: Product Pipeline Analysis Global Glucose Monitoring Device Market: Consolidation Landscape Appendix Companies Mentioned - Abbott Laboratories - Arkay, Inc. - Bayer Healthcare AG - F. Hoffmann-La Roche Ltd. - LifeScan For more information visit http://www.researchandmarkets.com/research/3t5jtr/glucose About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
